A new study conducted by Wake Forest University School of Medicine found that an insulin nasal spray can help treat Alzheimer's patients. Wake Forest University reported the results in a press release.
Key findings:
- The spray delivered insulin to “11 key brain regions associated with memory and cognition.”
- Participants that were classified as “cognitively normal” responded to the insulin nasal spray differently.
- Those classified as experiencing mild cognitive impairment showed “rapid initial uptake followed by quicker clearance” during treatment.
- ptau217 levels and cardiovascular factors influenced how women responded to the insulin nasal spray.
- Side effects were mild: minor headaches were experienced by two participants.
